BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6077686)

  • 1. [Clinical experiences with gestagen therapy of various gynecologic diseases].
    György G; László J
    Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686
    [No Abstract]   [Full Text] [Related]  

  • 2. A new progestogen-estrogen combination for gynecologic therapy and contraception.
    Linthorst G
    Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
    Willmes HG
    Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
    Jacobs C; Heinen G; Schmal E
    Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of a synthetic progestagen at low doses].
    Gaudefroy M
    Gynecol Prat; 1966; 17():337-43. PubMed ID: 5987259
    [No Abstract]   [Full Text] [Related]  

  • 7. [Handling of a synthetic progestative in a psychiatric milieu].
    Dubor P; Favre-Tissot M; Guyotat J; Haour P; Simonnet ; Vantheemsche G
    J Med Lyon; 1966 Oct; 47(106):1379-85. PubMed ID: 5928220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with ovariostatic drugs in premenopausal syndromes. Cytological control].
    Subrizi DA; Pieroni G
    Riv Ostet Ginecol; 1966 Jun; 21(6):320-6. PubMed ID: 5963561
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of noracycline administered in menstruation disorders on certain biological functions of the female organism. Effects on the protein metabolism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 May; 25(18):635-7. PubMed ID: 5429830
    [No Abstract]   [Full Text] [Related]  

  • 10. Lyndiol: evaluation of safety and efficacy as an oral contraceptive.
    Strade HA
    Curr Ther Res Clin Exp; 1966 May; 8(5):265-79. PubMed ID: 4956390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of dysfunctional uterine hemorrhages and amenorrheas using a progestagen-estrogen combination].
    Brehm H; Karsznia R; Prinz W; Schmidt G
    Med Monatsschr; 1972 Dec; 26(12):577-9. PubMed ID: 4663633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of noracycline administered in menstruation disorders on various biological functions of the female organism. The secretion of ovarian hormones].
    Jabloński K; Zymek-Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1971 Apr; 26(14):505-7. PubMed ID: 5581640
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical indications for the prescription of ovulation inhibitors in gynecologic practice].
    Willmes HG
    Med Welt; 1969 Mar; 10():526-31. PubMed ID: 4239080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of noracycline administered for dysmenorrhea on certain biologic functions of the female organism. Its effect on electrolyte metabolism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 Nov; 25(47):1789-92. PubMed ID: 5484511
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapeutic use of the sequentially administered oral ovulation inhibitor Ovanon].
    Gimes R; Tóth F
    Dtsch Med J; 1969 Dec; 20(23):718-9. PubMed ID: 5397037
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical investigations on the usefulness of Lyndiol for contraceptive and therapeutic purposes].
    Liebhart S; Trebicka-Kwiatkowska B
    Endokrynol Pol; 1966; 17(6):717-28. PubMed ID: 5341992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estroprogestinic associations in the preclimacteric syndrome: blood coagulation problems].
    Schubert L; Giarola P; Gibelli A; Iurlaro F
    G Gerontol; 1969 Nov; 17(11):1059-66. PubMed ID: 5397790
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
    Kaltreider DF
    Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical results of administration of gestagens (Anovlar 21 and Lyndiol 2,5) in endometriosis].
    Laudańska E
    Ginekol Pol; 1968 Sep; 39(9):1015-20. PubMed ID: 4881514
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic significance of the sequential estrogen-gestagen preparation "Ovara" in gynecologic endocrinology].
    Prudan R; Durdević LJ; Lekin M
    Med Pregl; 1977; 30(11-12):585-93. PubMed ID: 607143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.